CDRH’s ophthalmic devices advisory panel will look at the evidence supporting PMA approval of Alcon Laboratories Inc.’s AcrySof IQ Restor multifocal toric posterior chamber intraocular lens at a public meeting on Nov. 14, according to an FDA notice.
The company is seeking an indication for the IOL for primary implantation to correct aphakia and astigmatism in patients who...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?